Improve Research Reproducibility A Bio-protocol resource
- Home
- Protocols
-
Ask a
question
Favorite
The study is a randomised, open-label, multicentre and prospective trial. All patients meeting the inclusion and exclusion criteria should be invited to the trial, and then the participants will be randomly allocated into groups receiving clopidogrel plus aspirin or aspirin alone. A flow diagram summarising the processes in the present study is shown in figure 1.
Flow diagram of the study. mRS, modified Rankin Scale; NIHSS, National Institutes of Health Stroke Scale.
Copyright and License information: ©2018 Author(s) (or their employer(s)) 2018. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.
Post a Question0 Q&A
